Search Within

Catherine A O'Flaherty

Formats
  1. Journal Article (7)
  2. Meeting Abstract (5)
Groups
  1. Nursing (12)
  2. Department of Medicine (10)
  3. GDMT, Medicine (10)
  4. Gynecologic Medicine Service (10)
  5. Gynecology Disease Management Team (10)
  6. Solid Tumor Oncology Division (10)

More Groups

People
  1. Carol Aghajanian (10)
  2. David Spriggs (10)
  3. Paul Sabbatini (6)
  4. John Curtin (5)
  5. Steven Soignet (4)
  6. Fred Shapiro (3)

More People

Years
  1. 2010 (1)
  2. 2006 (1)
  3. 2004 (1)
  4. 2001 (1)
  5. 2000 (3)
  6. 1999 (1)

More Years

Publications
  1. Clinical Cancer Research (4)
  2. Journal of Clinical Oncology (3)
  3. Journal of Gynecologic Oncology Nursing (2)
  4. Gynecologic Oncology (1)
  5. International Journal of Cancer (1)
  6. Seminars in Oncology (1)
Publishers
  1. American Association for Cancer Research (4)
  2. American Society of Clinical Oncology (3)
  3. Elsevier Inc. (2)
  4. Society of Gynecologic Nurse Oncologists (2)
  5. John Wiley & Sons (1)

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CA125 response to bevacizumab in recurrent ovarian cancer
    Meeting Abstract

    O'Cearbhaill, R. E.; Zhou, Q.; Iasonos, A.; Diaz, J. P.; Tew, W. P.; Hensley, M. L.; O'Flaherty, C.; Aghajanian, C.; Spriggs, D. R.; Sabbatini, P.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • New chemotherapeutic agents in ovarian and gynecologic malignancies
    Journal Article

    O'Flaherty, C.
    Journal of Gynecologic Oncology Nursing (2006)

    Fulltext@MSK | Save
  • Intraperitoneal cisplatin with intraperitoneal gemcitabine in patients with epithelial ovarian cancer: Results of a phase I/II trial
    Journal Article

    Sabbatini, P.; Aghajanian, C.; Leitao, M.; Venkatraman, E.; Anderson, S.; Dupont, J.; Dizon, D.; O'Flaherty, C.; Bloss, J.; Chi, D.; more...
    Clinical Cancer Research (2004)

    Fulltext@MSK | Save
  • Early findings in a phase I study of PG-paclitaxel (CT-2103) in recurrent ovarian or peritoneal cancer
    Meeting Abstract

    Sabbatini, P.; Soignet, S.; Aghajanian, C.; Hensley, M.; Pezzulli, S.; O'Flaherty, C.; Wengrow, A.; Funt, S.; Chi, D.; Odujinrin, O.; more...
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Phase I trial of a synthetic Lewis(Y) - KLH conjugate vaccine on ovarian cancer patients
    Meeting Abstract

    Sabbatini, P.; Kudryashov, V.; Ragupathi, G.; Danishefsky, S.; Livingston, P.; Bornmann, W.; Spassova, M.; Zatorski, A.; Spriggs, D.; Aghajanian, C.; more...
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • A phase I/II trial of intraperitoneal (IP) cisplatin (CDDP) with IP gemcitabine (GEM) in patients (pts) with epithelial ovarian cancer
    Meeting Abstract

    Sabbatini, P.; Aghajanian, C.; Hensley, M.; Tong, W.; Soignet, S.; Hoskins, W.; O'Flaherty, C.; Pezzulli, S.; Barakat, R.; Spriggs, D.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Immunization of ovarian cancer patients with a synthetic Lewis(y)- protein conjugate vaccine: A phase 1 trial
    Journal Article

    Sabbatini, P. J.; Kudryashov, V.; Ragupathi, G.; Danishefsky, S. J.; Livingston, P. O.; Bornmann, W.; Spassova, M.; Zatorski, A.; Spriggs, D.; Aghajanian, C.; more...
    International Journal of Cancer (2000)

    Fulltext@MSK | Save
  • Update on the phase I vaccination trials for patients with ovarian, fallopian tubes, and primary peritoneal cancers
    Meeting Abstract

    O'Flaherty, C.
    Journal of Gynecologic Oncology Nursing (1999)

    Fulltext@MSK | Save
  • Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer
    Journal Article

    Aghajanian, C.; Fennelly, D.; Shapiro, F.; Waltzman, R.; Almadrones, L.; O'Flaherty, C.; O'Conner, K.; Venkatraman, E.; Barakat, R.; Curtin, J.; more...
    Journal of Clinical Oncology (1998)

    Fulltext@MSK | Save
  • Dose escalation of paclitaxel with high-dose carboplatin using peripheral blood progenitor cell support in patients with advanced ovarian cancer
    Journal Article

    Fennelly, D. W.; Aghajanian, C.; Shapiro, F.; Oflaherty, C.; Oconnor, K.; Curtin, J. P.; Crown, J. P.; Hoskins, W. J.; Spriggs, D. R.
    Seminars in Oncology (1997)

    Fulltext@MSK | Save